Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-06 12:57 pm Sale | 2026-02-28 | 13G | Immunocore Holdings plc IMCR | T. Rowe Price Investment Management, Inc. | 3,041,904 6.000% | -2,919,323 (-48.97%) | Filing History |
| 2026-02-17 10:28 am Sale | 2025-12-31 | 13G | Immunocore Holdings plc IMCR | T. Rowe Price Investment Management, Inc. | 5,961,227 11.800% | -1,090,591 (-15.47%) | Filing History |
| 2025-11-14 8:00 pm Purchase | 2025-08-20 | 13G | Immunocore Holdings plc IMCR | Bellevue Group AG | 2,796,803 5.600% | 2,796,803 (New Position) | Filing History |
| 2025-10-24 4:16 pm Purchase | 2025-10-17 | 13G | Immunocore Holdings plc IMCR | TANG CAPITAL MANAGEMENT LLC | 2,605,608 5.200% | 2,605,608 (New Position) | Filing History |
| 2025-10-03 4:16 pm Unchanged | 2025-09-30 | 13G | Immunocore Holdings plc IMCR | ELI LILLY & Co LLY | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-08-14 1:27 pm Purchase | 2025-06-30 | 13G | Immunocore Holdings plc IMCR | PRIMECAP MANAGEMENT CO | 3,772,234 7.510% | 1,103,684 (+41.36%) | Filing History |
| 2025-08-05 1:44 pm Purchase | 2025-07-31 | 13G | Immunocore Holdings plc IMCR | WELLINGTON MANAGEMENT GROUP LLP | 5,132,898 10.200% | 617,374 (+13.67%) | Filing History |
| 2025-08-05 1:34 pm Sale | 2025-06-30 | 13G | Immunocore Holdings plc IMCR | WELLINGTON MANAGEMENT GROUP LLP | 4,515,524 9.100% | -1,914,554 (-29.77%) | Filing History |
| 2025-05-14 10:47 am Purchase | 2025-03-31 | 13G | Immunocore Holdings plc IMCR | T. Rowe Price Investment Management, Inc. | 7,051,818 14.100% | 7,051,818 (New Position) | Filing History |
| 2025-05-12 10:44 am Purchase | 2025-03-31 | 13G | Immunocore Holdings plc IMCR | WELLINGTON MANAGEMENT GROUP LLP | 6,430,078 13.000% | 6,430,078 (New Position) | Filing History |
| 2025-02-14 4:01 pm Purchase | 2024-12-31 | 13G | Immunocore Holdings plc IMCR | Jallal Bahija | 4,493,139 8.200% | 4,493,139 (New Position) | Filing History |
| 2025-02-13 6:26 pm Purchase | 2024-12-31 | 13G | Immunocore Holdings plc IMCR | PRIMECAP MANAGEMENT CO | 2,668,550 5.330% | 2,668,550 (New Position) | Filing History |
| 2024-11-14 1:28 pm Unchanged | 2024-11-14 | 13G | Immunocore Holdings plc IMCR | T. Rowe Price Investment Management, Inc. | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-11-14 1:22 pm Unchanged | 2024-11-14 | 13G | Immunocore Holdings plc IMCR | PRICE T ROWE ASSOCIATES INC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-11-14 06:40 am Unchanged | 2024-11-14 | 13G | Immunocore Holdings plc IMCR | RTW INVESTMENTS LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-11-12 4:47 pm Unchanged | 2024-11-12 | 13G | Immunocore Holdings plc IMCR | Rock Springs Capital Management LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-11-08 10:52 am Unchanged | 2024-11-08 | 13G | Immunocore Holdings plc IMCR | WELLINGTON MANAGEMENT GROUP LLP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-09-10 1:49 pm Unchanged | 2024-09-10 | 13G | Immunocore Holdings plc IMCR | T. Rowe Price Investment Management, Inc. | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-03-11 08:19 am Unchanged | 2024-03-11 | 13G | Immunocore Holdings plc IMCR | FMR LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-03-07 9:45 pm Unchanged | 2024-03-07 | 13D | Immunocore Holdings plc IMCR | GENERAL ATLANTIC LLC | 0 0.000% | 0 (Unchanged) | Filing |